BMP1 and rheumatoid arthritis: However, the use of celastrol also demonstrated similarities to two out of three of the examined FDA-approved RA drugs (methotrexate and tocilizumab) in terms of the expression of some genes for example BMP1 and ERBB2 which support the therapeutic potency of celastrol in RA treatment.